These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 6644585)

  • 21. Physiologically based pharmacokinetic model for digoxin distribution and elimination in the rat.
    Harrison LI; Gibaldi M
    J Pharm Sci; 1977 Aug; 66(8):1138-42. PubMed ID: 894501
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dose- and time-dependent kinetics of the renal excretion of nitrofurantoin in the rabbit.
    Watari N; Aizawa K; Kaneniwa N
    J Pharm Sci; 1985 Feb; 74(2):165-70. PubMed ID: 3989686
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of a physiologically based pharmacokinetic model for estradiol in rats and humans: a biologically motivated quantitative framework for evaluating responses to estradiol and other endocrine-active compounds.
    Plowchalk DR; Teeguarden J
    Toxicol Sci; 2002 Sep; 69(1):60-78. PubMed ID: 12215661
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protein binding of β-lactam antibiotics in critically ill patients: can we successfully predict unbound concentrations?
    Wong G; Briscoe S; Adnan S; McWhinney B; Ungerer J; Lipman J; Roberts JA
    Antimicrob Agents Chemother; 2013 Dec; 57(12):6165-70. PubMed ID: 24080664
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics of probenecid and the effect of oral probenecid administration on the pharmacokinetics of cefazolin in mares.
    Donecker JM; Sams RA; Ashcraft SM
    Am J Vet Res; 1986 Jan; 47(1):89-95. PubMed ID: 3946913
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro and in vivo evaluation of the tissue-to-blood partition coefficient for physiological pharmacokinetic models.
    Lin JH; Sugiyama Y; Awazu S; Hanano M
    J Pharmacokinet Biopharm; 1982 Dec; 10(6):637-47. PubMed ID: 7182459
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma pharmacokinetics and urinary and biliary excretion of a new potent tripeptide HIV-1 protease inhibitor, KNI-272, in rats after intravenous administration.
    Kiriyama A; Fujita K; Takemura S; Kuramoto H; Kiso Y; Takada K
    Biopharm Drug Dispos; 1994 Oct; 15(7):617-26. PubMed ID: 7849237
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Physiologically based pharmacokinetic study on a cyclosporin derivative, SDZ IMM 125.
    Kawai R; Lemaire M; Steimer JL; Bruelisauer A; Niederberger W; Rowland M
    J Pharmacokinet Biopharm; 1994 Oct; 22(5):327-65. PubMed ID: 7791036
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differences in the pharmacokinetics of 4-amino-3-chlorophenyl hydrogen sulfate, a metabolite of resatorvid, in rats and dogs.
    Jinno F; Takeuchi T; Tagawa Y; Kondo T; Itoh T; Asahi S
    Drug Metab Dispos; 2012 Apr; 40(4):648-54. PubMed ID: 22203697
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prediction of diazepam disposition in the rat and man by a physiologically based pharmacokinetic model.
    Igari Y; Sugiyama Y; Sawada Y; Iga T; Hanano M
    J Pharmacokinet Biopharm; 1983 Dec; 11(6):577-93. PubMed ID: 6678311
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prediction of the disposition of beta-lactam antibiotics in humans from pharmacokinetic parameters in animals.
    Sawada Y; Hanano M; Sugiyama Y; Iga T
    J Pharmacokinet Biopharm; 1984 Jun; 12(3):241-61. PubMed ID: 6438301
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Absorption, distribution, and excretion of arbekacin after intravenous and intramuscular administration in rats].
    Mitomi N; Matsumoto T; Fujigaki M; Komiya I; Kai F
    Jpn J Antibiot; 1987 Feb; 40(2):357-64. PubMed ID: 3599384
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Distribution of quinidine in rats with carbon tetrachloride-intoxicated hepatic disease.
    Sugihara N; Furuno K; Kita N; Murakami T; Yata N
    J Pharmacobiodyn; 1992 Apr; 15(4):167-74. PubMed ID: 1494979
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Single-dose pharmacokinetics of Ro 17-2301 (AMA-1080), a monocyclic beta-lactam, in humans.
    Weidekamm E; Stoeckel K; Egger HJ; Ziegler WH
    Antimicrob Agents Chemother; 1984 Dec; 26(6):898-902. PubMed ID: 6395801
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics and the effect of probenecid on the renal excretion mechanism of diprophylline.
    Nadai M; Apichartpichean R; Hasegawa T; Nabeshima T
    J Pharm Sci; 1992 Oct; 81(10):1024-7. PubMed ID: 1432614
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatic and renal clearances of probenecid in the rat.
    Emanuelsson BM; Paalzow LK
    Pharmacology; 1989; 38(1):61-8. PubMed ID: 2727046
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Binding of amino beta-lactam antibiotics to soluble protein from rat intestinal mucosa--I. Purification of drug-binding protein.
    Iseki K; Mori K; Miyazaki K; Arita T
    Biochem Pharmacol; 1987 Jun; 36(11):1837-42. PubMed ID: 3579976
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics of beta-lactam antibiotics.
    Bergan T
    Scand J Infect Dis Suppl; 1984; 42():83-98. PubMed ID: 6597564
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Physiologically Based Pharmacokinetic Modeling: The Reversible Metabolism and Tissue-Specific Partitioning of Methylprednisolone and Methylprednisone in Rats.
    Yu R; Jusko WJ
    Drug Metab Dispos; 2024 Jun; 52(7):662-672. PubMed ID: 38653502
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Physiologically based pharmacokinetic prediction of p-phenylbenzoic acid disposition in the pregnant rat.
    Kawahara M; Nanbo T; Tsuji A
    Biopharm Drug Dispos; 1998 Oct; 19(7):445-53. PubMed ID: 9818711
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.